GBT
BIIB icon

Grove Bank & Trust’s Biogen BIIB Stock Holding History

Grove Bank & Trust’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.8K Sell
87
-1
-1% -$191 ﹤0.01% 572
2026
Q1 		$16.1K Buy
88
+3
+4% +$553 ﹤0.01% 565
2025
Q4 		$15K Buy
85
+34
+67% +$5.55K ﹤0.01% 579
2025
Q3 		$7.14K Hold
51
– – ﹤0.01% 662
2025
Q2 		$6.41K Sell
51
-393
-89% -$49K ﹤0.01% 667
2025
Q1 		$60.8K Buy
444
+319
+255% +$45.6K 0.01% 388
2024
Q4 		$19.1K Buy
125
+21
+20% +$3.54K ﹤0.01% 476
2024
Q3 		$20.2K Buy
104
+33
+46% +$6.9K ﹤0.01% 444
2024
Q2 		$16.5K Hold
71
– – ﹤0.01% 448
2024
Q1 		$15.3K Hold
71
– – ﹤0.01% 467
2023
Q4 		$18.4K Hold
71
– – ﹤0.01% 440
2023
Q3 		$18.2K Sell
71
-37
-34% -$9.9K ﹤0.01% 463
2023
Q2 		$30.8K Hold
108
– – 0.01% 415
2023
Q1 		$30K Buy
108
+16
+17% +$4.43K 0.01% 424
2022
Q4 		$25K Buy
+92
New +$26K 0.01% 438
2018
Q1 		– Sell
-143
Closed -$46K – 190
2017
Q4 		$46K Sell
143
-9
-6% -$2.89K 0.02% 304
2017
Q3 		$48K Sell
152
-118
-44% -$34.9K 0.02% 305
2017
Q2 		$73K Buy
270
+82
+44% +$21.7K 0.05% 206
2017
Q1 		$51K Hold
188
– – 0.04% 215
2016
Q4 		$53K Buy
+188
New +$55.7K 0.04% 204
2016
Q3 		– Sell
-12
Closed -$3K – 247
2016
Q2 		$3K Buy
+12
New +$3.16K ﹤0.01% 253

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Grove Bank & Trust's BIIB Position: Q2 2026 in Review

Grove Bank & Trust reduced its Biogen (BIIB) stake by 1.1% in Q2 2026, selling an estimated $191 and leaving 87 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #572.

Grove Bank & Trust first reported a position in BIIB in Q2 2016 and has held it in 21 quarters since. The position peaked at $73K in Q2 2017. 1,036 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Grove Bank & Trust held 87 shares of Biogen worth $18.8K as of Q2 2026.
  • Grove Bank & Trust sold 1 Biogen share in Q2 2026, an estimated $191.
  • Biogen made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #572 holding.
  • Grove Bank & Trust first reported a position in Biogen in Q2 2016 and has held it in 21 quarters since.
  • Grove Bank & Trust's Biogen position peaked at $73K in Q2 2017.
  • 1,036 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.